NEWS-CANCER - Team studies obinutuzumab for treating chronic lymphocytic leukemia

Two North Shore-LIJ Cancer Institute doctors, world-renowned for their research in chronic lymphocytic leukemia (CLL), weigh in on a German study of a new drug therapy for CLL in the March 20 edition of the New England Journal of Medicine, the North Shore-LIJ Health System announced today ...

http://medicalxpress.com/news/2014-03-team-obinutuzumab-chronic-lympho